Pharmather, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public, Subsidiary
- Established
- 2020-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.pharmather.com
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
Phase 2
Suspended
- Conditions
- Movement DisordersDyskinesiasCentral Nervous System DiseasesNervous System DiseasesNeurologic Manifestations
- Interventions
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- PharmaTher Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04912115
- Locations
- 🇺🇸
Investigative Site #6, Miami, Florida, United States
🇺🇸Investigative Site #1, Fountain Valley, California, United States
🇺🇸Investigative Site #7, Tucson, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath